ATE70449T1 - Zusammensetzungen von katecholischen butanen mit zink. - Google Patents

Zusammensetzungen von katecholischen butanen mit zink.

Info

Publication number
ATE70449T1
ATE70449T1 AT87907401T AT87907401T ATE70449T1 AT E70449 T1 ATE70449 T1 AT E70449T1 AT 87907401 T AT87907401 T AT 87907401T AT 87907401 T AT87907401 T AT 87907401T AT E70449 T1 ATE70449 T1 AT E70449T1
Authority
AT
Austria
Prior art keywords
zinc
compositions
catecholic
catecholic butanes
new compositions
Prior art date
Application number
AT87907401T
Other languages
English (en)
Inventor
Russell T Jordan
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE70449T1 publication Critical patent/ATE70449T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87907401T 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink. ATE70449T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/924,620 US4880637A (en) 1985-02-11 1986-10-28 Compositions of catecholic butanes with zinc
EP87907401A EP0288534B1 (de) 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink
PCT/US1987/002868 WO1988003026A1 (en) 1986-10-28 1987-10-27 Compositions of catecholic butanes with zinc

Publications (1)

Publication Number Publication Date
ATE70449T1 true ATE70449T1 (de) 1992-01-15

Family

ID=25450444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907401T ATE70449T1 (de) 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink.

Country Status (8)

Country Link
US (1) US4880637A (de)
EP (1) EP0288534B1 (de)
JP (1) JPH01501794A (de)
KR (1) KR880701556A (de)
AT (1) ATE70449T1 (de)
AU (1) AU616641B2 (de)
DE (1) DE3775387D1 (de)
WO (1) WO1988003026A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290442A4 (de) * 1986-11-19 1990-07-03 Chemex Pharmaceuticals Inc Arzneimittelzubereitungen und gemische daraus, organische zusammensetzungen und metallsalze.
US6046243A (en) * 1993-02-12 2000-04-04 Bernard Technologies, Inc. Compositions for sustained release of a gas
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
CA2185448A1 (en) * 1994-03-14 1995-09-21 James L. Mulshine Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
US6365787B1 (en) 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
US5837252A (en) * 1996-07-01 1998-11-17 Larreacorp, Ltd. Nontoxic extract of Larrea tridentata and method of making same
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2785804B1 (fr) * 1998-11-17 2002-10-18 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait de larrea divaricata ou de larrea tridentata pour ralentir le vieillissement cutane
US6787573B2 (en) * 1999-07-02 2004-09-07 Universiteit Utrecht Antiviral therapy
US6608108B2 (en) * 1999-10-15 2003-08-19 Johns Hopkins University Method for treatment of tumors using nordihydroguaiaretic acid derivatives
US6214874B1 (en) 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
US20060141029A1 (en) * 2003-05-20 2006-06-29 Erimos Pharmaceuticals Llc Methods and compositions for delivery of catecholic butanes for treatment of diseases
JP2007500229A (ja) * 2003-05-20 2007-01-11 ジョンズ・ホプキンズ・ユニバーシティ 腫瘍の治療のためのカテコールブタンの投与のための方法と組成物
US7728036B2 (en) 2003-05-20 2010-06-01 Erimos Pharmaceuticals, Llc Methods for delivery of catecholic butanes for treatment of tumors
US7420105B2 (en) 2004-03-11 2008-09-02 Carlsberg A/S Barley for production of flavor-stable beverage
CN100440843C (zh) * 2004-05-12 2008-12-03 华为技术有限公司 一种环网及其业务实现方法
PL1748767T3 (pl) 2004-05-28 2012-08-31 Unigen Inc 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
US8440648B2 (en) * 2004-07-20 2013-05-14 Erimos Pharmaceuticals Llc Methods and compositions for treatment of intraepithelial neoplasia
US20090022803A1 (en) * 2005-01-27 2009-01-22 Erimos Pharmaceuticals Llc Oral Formulations For Delivery of Catecholic Butanes Including Ndga Compounds
CN101150955B (zh) * 2005-01-27 2013-04-17 埃里莫斯医药品有限公司 递送包括ndga化合物的儿茶酚丁烷的口服制剂
KR20090006062A (ko) * 2006-02-23 2009-01-14 에리모스 파마슈티컬스 엘엘씨 인플루엔자 바이러스 감염의 치료 방법
US20070212331A1 (en) * 2006-03-07 2007-09-13 Baldassare Joseph J Methods and compositions for selectively killing cells
US9067875B2 (en) 2006-10-02 2015-06-30 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
EP2076252B1 (de) * 2006-10-02 2014-04-02 Erimos Pharmaceuticals LLC Tetra-substituierte ndga-derivate über etherbindungen und carbamat-bindungen und ihre synthese und pharmazeutische verwendung
US8153171B1 (en) * 2007-10-02 2012-04-10 Allen Jay Cohen Solution for dissolving pre-melanoma lesions and melanoma lesions including psoriasis, herpes simplex lesions and eczema lesions
US7597914B1 (en) * 2007-10-02 2009-10-06 Allen Jay Cohen Ala-septic pre-cancerous liquid dissolving solution and method
JP2011528719A (ja) 2008-07-21 2011-11-24 ユニジェン・インコーポレーテッド スキンホワイトニング（色を薄くする）化合物系列
KR102113823B1 (ko) 2011-03-24 2020-05-21 유니젠, 인크. 디아릴프로판의 제조를 위한 화합물 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404146A (en) * 1980-12-17 1983-09-13 Biosystems Research Inc. Metal oxyalkylates and method of making same
US4774229A (en) * 1982-04-05 1988-09-27 Chemex Pharmaceuticals, Inc. Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor
WO1988001509A1 (en) * 1986-08-25 1988-03-10 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
AU6330486A (en) * 1986-08-25 1988-03-24 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc
AU6737987A (en) * 1986-11-19 1988-06-16 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc

Also Published As

Publication number Publication date
AU616641B2 (en) 1991-11-07
EP0288534A1 (de) 1988-11-02
JPH01501794A (ja) 1989-06-22
US4880637A (en) 1989-11-14
KR880701556A (ko) 1988-11-03
EP0288534B1 (de) 1991-12-18
EP0288534A4 (de) 1989-02-23
AU8172487A (en) 1988-05-25
DE3775387D1 (de) 1992-01-30
WO1988003026A1 (en) 1988-05-05

Similar Documents

Publication Publication Date Title
ATE70449T1 (de) Zusammensetzungen von katecholischen butanen mit zink.
ES2020011A6 (es) Metodo de sintesis de composiciones que comprenden al menos un butano fenolico.
DK0623134T3 (da) Metalkomplekser af vandopløselige texaphyriner
KR850005272A (ko) 피부 보호 조성물의 제조방법
FR2653336B1 (fr) Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
ATE216877T1 (de) Verwendung von nsaids zur behandlung von plattenepithelkarzinom der mundhöhle und kehlkopf
MY100789A (en) Hair cosmetic composition
JPS57185208A (en) Skin cosmetic
DE3764491D1 (de) Haardauerwellenmittel.
ES8305352A1 (es) Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.
ATE215540T1 (de) Benzofuran-carboxamide und -sulfonamide
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
SE8703210L (sv) Hudvardskompositioner med keratolytisk och antiinflammatorisk aktivitet
IT1148273B (it) Composizione liquida per trattamento migliorativo di tessuti la quale contiene amido vegetale gelatinizzato,tensioattivo ed elettrolita
BR8008818A (pt) Peptidos farmacologicamente ativos e medicamentos contendo os mesmos
DE3581979D1 (de) Elektronenstrahlbehandlung zum erhoehen des haftvermoegens von polyesterfilmen.
DE68918280D1 (de) Kosmetische zusammensetzung auf der basis von chromo-carboxylaten.
DE3781116D1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
DE3686472T2 (de) Cardiotonische phenyloxazolone.
KR870003788A (ko) 모발자극 화합물
JPS5748915A (en) Tumor inhibiting pharmaceutical composition and use thereof
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
ATE56445T1 (de) Pharmacologisch aktive propionylanilide.
JPS5673013A (en) Permanent wave composition
MY102063A (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee